The activities of phosphohexose isomerase and 6-phosphogluconate dehydrogenase have been studied in the vaginal fluid of women from the gynaecological departments. Women from these departments gave a very high false positive rate, though no cases of carcinoma in situ were not detected by estimating phosphohexose isomerase levels. It gave considerably better results in malignancy than 6-phosphogluconate dehydrogenase. It is suggested that the use of phosphohexose isomerase might be of value in screening well women during a mass cytology programme.
SYNOPSIS
The activities of phosphohexose isomerase and 6-phosphogluconate dehydrogenase have been studied in the vaginal fluid of women from the gynaecological departments. Women from these departments gave a very high false positive rate, though no cases of carcinoma in situ were not detected by estimating phosphohexose isomerase levels. It gave considerably better results in malignancy than 6-phosphogluconate dehydrogenase. It is suggested that the use of phosphohexose isomerase might be of value in screening well women during a mass cytology programme.
The success of exfoliative cytology in the diagnosis of carcinoma of the cervix has highlighted the possibility of eliminating this disease by a mass screening programme. It is agreed that a mass survey based on exfoliative cytology presents many financial and technical disadvantages.
Failure of the assays of the vaginal fluid content of beta glucuronidase (Kasdon, Homburger, Yorshis, and Fishman, 1953;  Fishman, Green, Homburger, Kasdon, Nieburgs, McInnis, and Pund, 1954 ) and 6-phosphogluconate dehydrogenase (Bonham and Gibbs, 1962) to provide a basis for a mass screening programme has been a disappointment. Levels of both these enzymes have been raised in women with benign disease or have not been elevated in cases of carcinoma in situ or invasive carcinoma (Lawson, 1959;  Muir, Canti, and Williams, 1964; Bell and Egerton, 1965; Lawson and Watkins, 1965 Received for publication 21 March 1966 378 carcinoma is unimportant; provided that it measures a reaction of the cervical and vaginal epithelium to abnormalities, amongst these abnormalities would be carcinoma.
Another major requirement of any mass screening technique is that it should be robust and easy to assay. Evidence in this paper suggests that the glycolytic enzyme, phosphohexose isomerase, will fill all these requirements.
Phosphohexose isomerase has been widely studied in clinical conditions. Its main use has been in the assessment of carcinoma of the breast. Bodansky in 1954 followed up cases of carcinoma of the breast and found that serial estimations of the serum phosphohexose isomerase activity gave the best guide to the patient's short-term prognosis. Joplin and Jegatheesan (1962) and Jegatheesan and Joplin (1962) confirmed Bodansky's work and found that the enzyme was by far the most reliable of the serum enzymes in prognosis. Jegatheesan (1959) and Muir and Fawcett (1965) found that carcinomatous human mammary tissue had elevated enzyme levels as compared with normal breast tissue. Weber and Cantero (1957) , in a study of a variety of hepatomas, found that in Norikoff hepatoma the phosphohexose isomerase content was raised. Morris (1963) showed that in Morris hepatoma 5123-D and 7800, phosphohexose isomerase was not increased, but its level was not as depressed as were some of the other enzymes of glycolysis. Phosphohexose isomerase is a stable enzyme and is relatively easily estimated.
MATERIALS
The sources of the materials for this study were samples from women attending the gynaecological departments of the Bedford General Hospital and the Luton and Dunstable Hospital.
METHODS
The samples were collected and prepared in a similar manner to that of Bonham and Gibbs (1962) . The assay of 6-phosphogluconate dehydrogenase used was that of Glock and Mclean (1953) . Phosphohexose isomerase assay used was that of Bodansky (1954) Fig. 2 the activities on these cases are compared with the activities of 6-phosphogluconate dehydrogenase.
Of the seven cases with phosphohexose isomerase levels greater than 3 ,umoles per minute per gram, four samples had no detectable 6-phosphogluconate dehydrogenase activity in the samples, while two samples had 6-phosphogluconate dehydrogenase activities of less than 80 units per gram. In the remaining case the 6-phosphogluconate dehydrogenase activity was greater than 80 units per gram dry weight. Of these 38 samples only one had an elevated 6-phosphogluconate dehydrogenase; 29 had no detectable 6-phosphogluconate dehydrogenase activity. Figure 5 . There is an expectedly high incidence of elevated phosphohexose isomerase during menstruation. There is a peak between the 12th and 16th days during the ovulatory phase, which then falls between days 16 and 20, rising again during days 20 to 24 until the end of the cycle. Table III shows the results in post-menopausal women; both normal women and cases with benign gynaecological lesions are included. There is obviously an increase in the incidence of elevated enzyme levels in this group when compared with pre-menopausal women. The increased occurrence of elevated levels becomes more marked when they are compared with the apparently normal premenopausal women. In Fig. 6 In Table V the results of the 13 ca, carcinoma of the cervix are shown. 1 samples taken from these cases; of th not detected by estimating 6-phosphc hydrogenase, while all but one wa phosphohexose isomerase. lesion; also that of the smears discarded, he would not miss a case of carcinoma in situ. This is a useful aspect of enzymology, and is a possibility which should be followed up on a large scale; the simplicity of automation would make a large-scale trial relatively easy.
